LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 44.89 | 771.67 | 2640 | 5541 | 0.4764 | 0.5410 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 44.89 | 771.67 | 2435 | 5541 | 0.4394 | 0.4979 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 47.11 | 771.67 | 2787 | 5941 | 0.4691 | 0.5466 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 47.11 | 771.67 | 2593 | 5941 | 0.4364 | 0.5092 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 49.33 | 771.67 | 2998 | 6392 | 0.4690 | 0.5604 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 49.33 | 771.67 | 2725 | 6392 | 0.4263 | 0.5123 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 51.55 | 771.67 | 3148 | 6829 | 0.4609 | 0.5635 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 51.55 | 771.67 | 2923 | 6829 | 0.4280 | 0.5271 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.77 | 771.67 | 3334 | 7256 | 0.4595 | 0.5724 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.77 | 771.67 | 3058 | 7256 | 0.4214 | 0.5309 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 55.99 | 771.67 | 3528 | 7690 | 0.4588 | 0.5813 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 55.99 | 771.67 | 3239 | 7690 | 0.4212 | 0.5411 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.21 | 771.67 | 3749 | 8085 | 0.4637 | 0.5942 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.21 | 771.67 | 3459 | 8085 | 0.4278 | 0.5568 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 60.44 | 771.67 | 3967 | 8530 | 0.4650 | 0.6037 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 60.44 | 771.67 | 3636 | 8530 | 0.4262 | 0.5639 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 62.66 | 771.67 | 4174 | 8978 | 0.4649 | 0.6109 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 62.66 | 771.67 | 3891 | 8978 | 0.4334 | 0.5793 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 64.88 | 771.67 | 4336 | 9447 | 0.4590 | 0.6123 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 64.88 | 771.67 | 4073 | 9447 | 0.4311 | 0.5846 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 67.10 | 771.67 | 4556 | 9800 | 0.4649 | 0.6230 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 67.10 | 771.67 | 4269 | 9800 | 0.4356 | 0.5944 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 69.32 | 771.67 | 4744 | 10212 | 0.4646 | 0.6281 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 69.32 | 771.67 | 4407 | 10212 | 0.4316 | 0.5962 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 71.54 | 771.67 | 4968 | 10532 | 0.4717 | 0.6386 | MN20160304_L01 | J22 |